Please login to the form below

Not currently logged in
Email:
Password:

Havas appoints Ben Davies as European CEO

He will take over from Ed Stapor at the healthcare communications agency

Havas European CEO Ben DaviesHavas Worldwide Health has appointed Ben Davies as the new CEO of its European division.

The former CEO of Pan Advertising officially starts at Havas on September 3, when he takes over from Ed Stapor, who will continue at the agency until the end of the year and then take up a new role within the wider Havas network.

Davies has 26 years experience in healthcare marketing and advertising, latterly serving not just at Pan but also as co-founder and EU chair of Indigenus, the independent global network to which Pan belonged.

In his new role Davies will report to New York–based Havas Worldwide Health managing partners and CEOs Doug Burcin and Donna Murphy.

Commenting on the appointment, Burcin said: “We are very excited to welcome Ben to our team. His background in healthcare marketing and advertising is impressive and will be a tremendous contribution to our continued success in Europe.

“Ed's done a great job in this role and we have full confidence that under Ben's leadership, we will continue to grow and innovate in Europe.”

The agency has already boosted its UK operations this summer, acquiring Manchester-based digital agency Creative Lynx and appointing Davies' former colleague at Pan Claire Dobbs as managing director for its London office.

31st August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Packer Forbes Communications

Packer Forbes is an award-winning independent healthcare communications consultancy. Our integrated approach ensures that our clients benefit from a compelling...

Latest intelligence

Harnessing complexity
Companion diagnostics in oncology...
"Not Another Boring Survey?"
Winning over HCPs… How to Increase Participant Engagement in Healthcare Market Research...
What pharma needs to know about genomic data in 2016
Consultant David Cooney from Blue Latitude Health talks us through what this progress in genomics means for pharma in 2016....

Infographics